Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration

This retrospective study evaluated the real-world safety and effectiveness of switching to intravitreal brolucizumab for refractory neovascular age-related macular degeneration (nAMD). A total of 81 patients who received brolucizumab injections as switch therapy were followed for more than 3 months....

Descripción completa

Detalles Bibliográficos
Autores principales: Yeom, Hoseok, Kwon, Hye Ji, Kim, Yoon Jeon, Lee, Junyeop, Yoon, Young Hee, Lee, Joo Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349130/
https://www.ncbi.nlm.nih.gov/pubmed/37452068
http://dx.doi.org/10.1038/s41598-023-38173-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349130/
https://www.ncbi.nlm.nih.gov/pubmed/37452068
http://dx.doi.org/10.1038/s41598-023-38173-y

Ejemplares similares